Stock Report

All about this stock under one free report Last Updated: 22-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Ascendis Pharma A/S - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$237.59

up-down-arrow $0.87 (0.37%)

As on 21-Sep-2026 16:00EDT

Market cap

info icon

$15,572 Mln

Revenue (TTM)

info icon

$1,054 Mln

P/E Ratio

info icon

18.5

P/B Ratio

info icon

9.5

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 37.60 118.23 114.85 106.83 190.92
EBIT 227.10 3,289.10 136.39 28.59 16.39
Net Profit -67.11 641.49 378.76 48.00 29.56
EPS -68.94 606.55 353.27 45.08 27.26
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -88.07-1,243.705.73-18.33-84.63
Net Margin info ----71.69----
Return on equity info -118.16-100.14--163.18300.78
Return on Capital info -50.41-49.64---30.01-56.08
Return on Assets info -35.21-39.2931.68-17.65-37.71
Debt to Equity (x) info ----0.27-5.35-8.10

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
--
-30.01
-56.08
-65.14
-59.07
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
--
163.18
300.78
-818.43
-101.69
Peer Median
-40.43
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

31.68

Higher than Peers by 63.14

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
31.68
-17.65
-37.71
-50.27
-53.64
Peer Median
-31.46
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

5.73

Higher than Peers by 84.03

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
5.73
-18.33
-84.63
-161.25
-1,068.30
Peer Median
-78.30
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

71.69

Higher than Peers by 160.61

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
71.69
-31.67
-103.97
-180.51
-1,139.63
Peer Median
-88.92
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

Higher than Peers by 0.00

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
0.00
--
--
--
--
Peer Median
0.00
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

114.85

Higher than Peers by 58.32

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
114.85
0.90
0.36
4.21
5.58
Peer Median
56.53
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

136.39

Higher than Peers by 137.03

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
136.39
58.80
28.45
21.33
-43.85
Peer Median
-0.64
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

378.76

Higher than Peers by 385.84

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
378.76
42.07
21.47
17.45
-52.04
Peer Median
-7.08
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

353.27

Higher than Peers by 338.61

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
353.27
0.44
0.26
0.18
-0.46
Peer Median
14.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

816.12

Higher than Peers by 825.42

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
816.12
--
--
--
--
Peer Median
-9.30
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.27

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
0.27
-5.35
-8.10
-5.10
2.35
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.05

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
0.05
-2.99
-4.65
-2.99
1.62
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

2.99

Lower than Peers by 2.80

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
2.99
1.04
1.17
0.95
1.29
Peer Median
5.79
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.32

Lower than Peers by 3.33

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
2.32
0.76
0.84
0.67
1.11
Peer Median
5.66
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

1.62

Higher than Peers by 3.71

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
1.62
-1.64
-4.70
-9.76
-17.82
Peer Median
-2.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

21.25

Higher than Peers by 2.21

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
21.25
22.79
45.73
13.45
23.27
Peer Median
19.04
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.44

Higher than Peers by 0.38

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
0.44
0.56
0.36
0.28
0.05
Peer Median
0.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
--
85.52
101.52
32.72
50.35
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
--
1,056.70
2,081.92
1,397.01
3,100.85
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
--
331.01
787.97
804.62
2,414.27
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ascendis Pharma A/S - ADR
--
811.21
1,395.47
625.11
736.93
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...